PeakData, a Swiss company that develops health technologies, earned $12 million in a Series A round led by AlbionVC and included Octopus Ventures and Heal Capital as participants.
Tech Funding News reports that PeakData has developed an artificial intelligence (AI) platform to assist pharmaceutical companies in connecting with the most relevant and powerful healthcare practitioners (HCP).
PeakData, a Swiss company that develops health technologies, earned $12 million in a Series A round led by AlbionVC and included Octopus Ventures and Heal Capital as participants.
Tech Funding News reports that PeakData has developed an artificial intelligence (AI) platform to assist pharmaceutical companies in connecting with the most relevant and powerful healthcare practitioners (HCP).
Using the platform, pharmaceutical companies may track and find out more information about the HCPs who are most crucial to their projects. The tool, according to the study, employs AI to grade HCPs based on their digital influence, relevance, and impact on their target market while also keeping track of their status over time.
“We consider PeakData as filling a big vacuum in the way our customers obtain and analyze this data in order to enhance the conversations they are having with a much greater spectrum of HCPs in their region,” says Patrick De Boer, co-founder of PeakData.
According to Christoph Ruedig, a partner at AlbionVC, it is crucial for pharmaceutical firms to find suitable therapeutic experts and healthcare specialists for their medications. They may now communicate with local, national, and worldwide medical specialists who have an impact on clinical decision-making thanks to PeakData.
According to research in the HIPAA Journal, 692 serious healthcare data breaches were reported between July 2021 and June 2022, exposing or unlawfully releasing the information of 42,431,699 individuals.
